These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23842553)

  • 1. A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].
    Garzon-Muvdi T; Pradilla G; Ruzevick JJ; Bender M; Edwards L; Grossman R; Zhao M; Rudek MA; Riggins G; Levy A; Tamargo RJ
    Neurosurgery; 2013 Oct; 73(4):719-28; discussion 729. PubMed ID: 23842553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.
    Pradilla G; Garzon-Muvdi T; Ruzevick JJ; Bender M; Edwards L; Momin EN; Thompson RC; Tamargo RJ
    Neurosurgery; 2012 Mar; 70(3):747-56; discussion 756-7. PubMed ID: 21915076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage.
    Chaichana KL; Levy AP; Miller-Lotan R; Shakur S; Tamargo RJ
    Stroke; 2007 Dec; 38(12):3266-71. PubMed ID: 17962599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.
    Momin EN; Schwab KE; Chaichana KL; Miller-Lotan R; Levy AP; Tamargo RJ
    Neurosurgery; 2009 Nov; 65(5):937-45; discussion 945. PubMed ID: 19834407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice can be prevented with a glutathione peroxidase mimetic.
    Froehler MT; Kooshkabadi A; Miller-Lotan R; Blum S; Sher S; Levy A; Tamargo RJ
    J Clin Neurosci; 2010 Sep; 17(9):1169-72. PubMed ID: 20541941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of haptoglobin genotype as a risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Ateia AM; Elbassiouny A; El-Nabi SH; Fahmy NA; Ibrahim MH; El-Garawani I; Geba KM; Khalaf M
    Clin Neurol Neurosurg; 2020 Dec; 199():106296. PubMed ID: 33069930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats.
    Gabikian P; Clatterbuck RE; Eberhart CG; Tyler BM; Tierney TS; Tamargo RJ
    Stroke; 2002 Nov; 33(11):2681-6. PubMed ID: 12411661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage.
    Borsody M; Burke A; Coplin W; Miller-Lotan R; Levy A
    Neurology; 2006 Mar; 66(5):634-40. PubMed ID: 16436647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
    J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.
    Kawakita F; Fujimoto M; Liu L; Nakano F; Nakatsuka Y; Suzuki H
    Mol Neurobiol; 2017 Oct; 54(8):6624-6633. PubMed ID: 27738873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits.
    Pradilla G; Wang PP; Legnani FG; Ogata L; Dietsch GN; Tamargo RJ
    J Neurosurg; 2004 Jul; 101(1):88-92. PubMed ID: 15255256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage.
    Wang HB; Wang WQ; Wu QJ; Hou YJ; Li HX; Yang HJ; Yang MF; Sun BL; Zhang ZY
    ACS Chem Neurosci; 2020 Sep; 11(18):2869-2880. PubMed ID: 32786302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting C/EBP homologous protein with siRNA attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    He Z; Ostrowski RP; Sun X; Ma Q; Tang J; Zhang JH
    Exp Neurol; 2012 Dec; 238(2):218-24. PubMed ID: 22944263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage.
    Zhou C; Yamaguchi M; Colohan AR; Zhang JH
    J Cereb Blood Flow Metab; 2005 May; 25(5):572-82. PubMed ID: 15729295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.
    Lin CL; Dumont AS; Calisaneller T; Kwan AL; Hwong SL; Lee KS
    Surg Neurol; 2005 Sep; 64(3):201-5; discussion 205-6. PubMed ID: 16099244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasorelaxing cell permeant phosphopeptide mimetics for subarachnoid hemorrhage.
    Morone PJ; Yan W; Adcock J; Komalavilas P; Mocco J; Thompson RC; Brophy C; Cheung-Flynn J
    Eur J Pharmacol; 2021 Jun; 900():174038. PubMed ID: 33737008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rosiglitazone in the proliferation of vascular smooth muscle cells after experimental subarachnoid hemorrhage.
    Cheng MF; Song JN; Li DD; Zhao YL; An JY; Sun P; Luo XH
    Acta Neurochir (Wien); 2014 Nov; 156(11):2103-9. PubMed ID: 25139403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant osteopontin attenuates experimental cerebral vasospasm following subarachnoid hemorrhage in rats through an anti-apoptotic mechanism.
    He J; Liu M; Liu Z; Luo L
    Brain Res; 2015 Jun; 1611():74-83. PubMed ID: 25779039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose lipopolysaccharide injection prior to subarachnoid hemorrhage modulates Delayed Deterioration associated with vasospasm in subarachnoid hemorrhage.
    Smithason S; Moore SK; Provencio JJ
    Acta Neurochir Suppl; 2013; 115():253-8. PubMed ID: 22890677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.